References
- Anderson, T.M., McMahon, J.J., Nwogu, C.E., Pombo, M.W., Urschel, J.D., Driscoll, D.L., and Lele, S.B. (2001). Pulmonary resection in metastatic uterine and cervical malignancies. Gynecol. Oncol. 83, 472-476. https://doi.org/10.1006/gyno.2001.6427
- Cai, Z., Tchou-Wong, K.M., and Rom, W.N. (2011). NF-kappaB in lung tumourigenesis. Cancers 3, 4258-4268. https://doi.org/10.3390/cancers3044258
- Chambers, A.F., Groom, A.C., and MacDonald, I.C. (2002). Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer. 2, 563-572. https://doi.org/10.1038/nrc865
- DeFilippis,R.A., Goodwin, E.C., Wu, L., and DiMaio, D. (2003). Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J. Viol. 77, 1551-1563.
-
Dolcet, X., Llobet, D., Pallares, J., and Matias-Guiu, X. (2005). NF-
${\kappa}B$ in development and progression of human cancer. Virchows. Arch. 446, 475-482. https://doi.org/10.1007/s00428-005-1264-9 - Esencay, M., Newcomb, E.W., and Zagzag, D. (2010). HGF upregulates CXCR4 expression in gliomas via NF-kappaB. Implications for glioma cell migration. J. Neurooncol. 99, 33-40. https://doi.org/10.1007/s11060-010-0111-2
- Fardini, Y., Dehennaut, V., Lefebvre, T., and Issad, T. (2013). OGlcNAcylation. A new cancer hallmark? Front. Endocrinol. 4, 1-14.
- Helbig, G., Christopherson, K.W., Bhat-Nakshatri, P., Kumar, S., Kishimoto, H., Miller, K.D., Broxmeyer, H.E., and Nakshatri, H. (2003). NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J. Biol. Chem. 278, 21631-21638. https://doi.org/10.1074/jbc.M300609200
- Jozwiak, P., Forma, E., Brys, M., and Krzeslak, A. (2014). OGlcNAcylation and metabolic reprograming in cancer. Front. Endocrinol. 5, 1-13.
- Kato, M., Kitayama, J., Kazama, S., and Nagawa, H. (2003). Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer. Res. 5, 144-150. https://doi.org/10.1186/bcr627
- Kucia, M., Jankowski, K., Reca, R., Wysoczynski, M., Bandura, L., Allendorf, D.J., Zhang, J., Ratajczak, J., and Ratajczak, M.Z. (2004). CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J. Mol. Histol. 35, 233-245.
- Ma, Z., Vocadlo, D.J., and Vosseller, K. (2013). Hyper-OGlcNAcylation is anti-apoptotic and maintains constitutive NF-kappaB activity in pancreatic cancer cells. J. Biol. Chem. 288, 15121-15130. https://doi.org/10.1074/jbc.M113.470047
- Nair, A., Venkatraman, M., Maliekal, T.T., Nair, B., and Karunagaran, D. (2003). NF-kappaB is constitutively activated in high grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene 22, 50-58. https://doi.org/10.1038/sj.onc.1206043
- Reinhardt, M.J., Ehritt-Braun, C., Vogelgesang, D., Ihling, C., Hogerle, S., Mix, M., Moser, E., and Krause, T.M. (2001). Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDFG PET. Radiology 218, 776-782. https://doi.org/10.1148/radiology.218.3.r01mr19776
- Sekula, M., Miekus, K., and Majka, M. (2014). Downregulation of the CXCR4 receptor inhibits cervical carcinoma metastatic behavior in vitro and in vivo. Int. J. Oncol. 44, 1853-1860. https://doi.org/10.3892/ijo.2014.2383
- Siegel, R.L., Miller,K.D., and Jemal, A. (2015). Cancer statistics, 2015. CA. Cancer. J. Clin. 65, 5-29. https://doi.org/10.3322/caac.21254
- Sironi, S., Buda, A., Picchio, M., Perego, P., Moreni, R., Pellegrino, A., Colombo, M., Mangioni, C., Messa, C., and Fazio, F. (2006). Lymph node metastasis in patients with clinical early-stage cervical cancer. Detection with integrated FDG PET/CT. Radiology 238, 272-279. https://doi.org/10.1148/radiol.2381041799
- Spano, D., Heck, C., De Antonellis, P., Christofori, G., and Zollo, M. (2012). Molecular networks that regulate cancer metastasis. Semin. Cancer. Biol. 22, 234-249. https://doi.org/10.1016/j.semcancer.2012.03.006
- Taichman, R.S., Cooper, C., Keller, E.T., Pienta, K.J., Taichman, N.S., and McCauley, L.K. (2002). Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer. Res. 62, 1832-1837.
- Tellis, C.J., and Beechler, C.R. (1982). Pulmonary metastasis of carcinoma of the cervix: a retrospective study. Cancer 49, 705-1709.
- Thanapprapasr, D., Nartthanarung, A., Likittanasombut, P., Na Ayudhya, N.I., Charakorn, C., Udomsubpayakul, U., Subhadarbandhu, T., and Wilailak, S. (2010). Bone metastasis in cervical cancer patients over a 10-year period. Int. J. Gynecol. Cancer 20, 373-378. https://doi.org/10.1111/IGC.0b013e3181d4a0a1
- Wang, X., and Adjei, A.A. (2015). Lung cancer and metastasis:New opportunities and challenges. Cancer Metastasis. Rev. 34, 169-171. https://doi.org/10.1007/s10555-015-9562-4
- Yang, W.H., Park, S.Y., Nam, H.W., Kim, D.H., Kang, J.G., Kang, E.S., Kim, Y.S., Lee, H.C., Kim, K.S., and Cho, J.W. (2008). NF-kappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions. Proc. Natl. Acad. Sci. USA 105, 17345-17350. https://doi.org/10.1073/pnas.0806198105
- Zhi, Y., Lu, H., Duan, Y., Sun, W., Guan, G., Dong, Q., and Yang, C. (2015). Involvement of the Nuclear Factor-KappaB signaling pathway in the regulation of CXC chemokine receptor-4 expression in neuroblastoma cells induced by tumor necrosis factor-alpha. Int. J. Mol. Med. 35, 349-357. https://doi.org/10.3892/ijmm.2014.2032
- Zlotnik., A. (2006a). Chemokines and cancer: Int. J. Cancer. 119, 2026-2029. https://doi.org/10.1002/ijc.22024
- Zlotnik., A. (2006b). Involvement of chemokine receptors in organspecific metastasis. Contrib. Microbiol.13,191-199.
- Zlotnik., A. (2008). New insights on the role of CXCR4 in cancer metastasis. J. Pathol. 215, 211-213. https://doi.org/10.1002/path.2350
Cited by
- Role of miR-520b in non-small cell lung cancer vol.16, pp.5, 2018, https://doi.org/10.3892/etm.2018.6732
- NF-κB signaling and crosstalk during carcinogenesis vol.2, pp.None, 2017, https://doi.org/10.1051/fopen/2019010
- Eugenol inhibits non‐small cell lung cancer by repressing expression of NF‐κB‐regulated TRIM59 vol.33, pp.5, 2017, https://doi.org/10.1002/ptr.6352
- Hyperglycemia-Induced Aberrant Cell Proliferation; A Metabolic Challenge Mediated by Protein O-GlcNAc Modification vol.8, pp.9, 2017, https://doi.org/10.3390/cells8090999
- Molecular Mechanisms of Anticancer Activities of Puerarin vol.12, pp.None, 2020, https://doi.org/10.2147/cmar.s233567
- CFTR Regulates the Proliferation, Migration and Invasion of Cervical Cancer Cells by Inhibiting the NF-κB Signalling Pathway vol.12, pp.None, 2017, https://doi.org/10.2147/cmar.s252296
- Functional Analysis of O -GlcNAcylation in Cancer Metastasis vol.10, pp.None, 2017, https://doi.org/10.3389/fonc.2020.585288
- Quercetin and cervical cancer: a view of great scope vol.29, pp.11, 2020, https://doi.org/10.1007/s00044-020-02622-4
- O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers vol.12, pp.None, 2017, https://doi.org/10.3389/fimmu.2021.772304
- Regulation of Nuclear Factor-kappaB Function by O-GlcNAcylation in Inflammation and Cancer vol.9, pp.None, 2017, https://doi.org/10.3389/fcell.2021.751761
- Glycosylation in Cervical Cancer: New Insights and Clinical Implications vol.11, pp.None, 2021, https://doi.org/10.3389/fonc.2021.706862
- Protein Substrates Engage the Lumen of O-GlcNAc Transferase’s Tetratricopeptide Repeat Domain in Different Ways vol.60, pp.11, 2021, https://doi.org/10.1021/acs.biochem.0c00981
- Role and Function of O-GlcNAcylation in Cancer vol.13, pp.21, 2017, https://doi.org/10.3390/cancers13215365
- O-GlcNAcylation protein disruption by Thiamet G promotes changes on the GBM U87-MG cells secretome molecular signature vol.18, pp.1, 2017, https://doi.org/10.1186/s12014-021-09317-x